tradingkey.logo

Embecta Corp

EMBC
查看详细走势图
12.080USD
+0.160+1.34%
收盘 12/24, 13:00美东报价延迟15分钟
706.63M总市值
7.38市盈率 TTM

Embecta Corp

12.080
+0.160+1.34%
盘中分时
1分
30分
1小时
日k
周k
月k
日k

今天

+1.34%

5天

+1.60%

1月

-17.09%

6月

+23.01%

今年开始到现在

-41.50%

1年

-40.76%

查看详细走势图

TradingKey Embecta Corp股票评分

单位: USD 更新时间: 2025-12-23

操作建议

Embecta Corp当前公司基本面数据相对健康,增长潜力很大。当前估值合理,在医疗设备与耗材行业排名54/208位。机构持股占比非常高,近一月多位分析师给出公司评级为持有。最高目标价16.67。中期看,股价处于下降通道。近一个月,市场表现较差,但公司基本面和技术面得分较高。目前股价在压力位和支撑位之间,可以做区间波段操作。

Embecta Corp评分

相关信息

行业排名
54 / 208
全市场排名
136 / 4568
所属行业
医疗设备与耗材

压力支撑

由于公司未披露,未能获取相关数据

多维评测

本期评分
上期评分

分析师目标

根据 4 位分析师
持有
评级
16.667
目标均价
+50.83%
涨幅空间
数据免责声明:分析师评级与目标价由LSEG提供,仅供参考,不应当作投资建议

Embecta Corp亮点

亮点风险
Embecta Corp. is a global medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. The Company has a portfolio of marketed products, including a variety of pen needles, syringes and safety injection devices. Its pen needles are sterile, single-use, medical devices, designed to be used in conjunction with pen injectors that inject insulin or other diabetes medications. It also sells safety pen needles, which have shields on both ends of the cannula that automatically deploy after the injection to help prevent needlestick exposure and injury during injection and disposal. Its traditional and safety pen needles are compatible and frequently used with pen injectors in the market. It sells sterile, single-use insulin syringes, which are used to inject insulin drawn from insulin vials. It also sells safety insulin syringes. It distributes its products through a variety of channels, including retail, hospitals and pharmacies.
利润高增长
公司净利润处于行业前列,最新年度总收入1.08B美元
高分红
公司属于高分红公司,最新股息支付率38.36%
估值低估
公司最新PE估值7.29,处于3年历史低位
机构减仓
最新机构持股58.75M股,环比减少0.01%
HACAX持仓
明星投资者HACAX持仓,最新持仓市值1.05K

Embecta Corp新闻

即将为您带来更多新闻,敬请期待。。。

财务指标

每股收益

由于公司未披露,未能获取相关数据

营业总收入

由于公司未披露,未能获取相关数据

Embecta Corp简介

Embecta Corp. is a global medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. The Company has a portfolio of marketed products, including a variety of pen needles, syringes and safety injection devices. Its pen needles are sterile, single-use, medical devices, designed to be used in conjunction with pen injectors that inject insulin or other diabetes medications. It also sells safety pen needles, which have shields on both ends of the cannula that automatically deploy after the injection to help prevent needlestick exposure and injury during injection and disposal. Its traditional and safety pen needles are compatible and frequently used with pen injectors in the market. It sells sterile, single-use insulin syringes, which are used to inject insulin drawn from insulin vials. It also sells safety insulin syringes. It distributes its products through a variety of channels, including retail, hospitals and pharmacies.
公司代码EMBC
公司Embecta Corp
CEOKurdikar (Devdatt)
网址https://www.embecta.com/

常见问题

Embecta Corp(EMBC)的当前股价是多少?

Embecta Corp(EMBC)的当前股价是 12.080。

Embecta Corp的股票代码是什么?

Embecta Corp的股票代码是EMBC。

Embecta Corp股票的52周最高点是多少?

Embecta Corp股票的52周最高点是21.230。

Embecta Corp股票的52周最低点是多少?

Embecta Corp股票的52周最低点是9.200。

Embecta Corp的市值是多少?

Embecta Corp的市值是706.63M。

Embecta Corp的净利润是多少?

Embecta Corp的净利润为95.40M。

现在Embecta Corp(EMBC)的股票是买入、持有还是卖出?

根据分析师评级,Embecta Corp(EMBC)的总体评级为持有,目标价格为16.667。

Embecta Corp(EMBC)股票的每股收益(EPS TTM)是多少

Embecta Corp(EMBC)股票的每股收益(EPS TTM)是1.636。
KeyAI